BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32559743)

  • 1. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
    Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
    J Neurosurg; 2020 Jun; 134(5):1399-1408. PubMed ID: 32559743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma.
    Kelley MJ; Shi J; Ballew B; Hyland PL; Li WQ; Rotunno M; Alcorta DA; Liebsch NJ; Mitchell J; Bass S; Roberson D; Boland J; Cullen M; He J; Burdette L; Yeager M; Chanock SJ; Parry DM; Goldstein AM; Yang XR
    Hum Genet; 2014 Oct; 133(10):1289-97. PubMed ID: 24990759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
    Zuckerman SL; Bilsky MH; Laufer I
    World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
    Pan Y; Lu L; Chen J; Zhong Y; Dai Z
    J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
    Gill CM; Fowkes M; Shrivastava RK
    Neurosurgery; 2020 Feb; 86(2):E118-E123. PubMed ID: 31504814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T gene isoform expression pattern is significantly different between chordomas and notochords.
    Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
    Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.
    Jones PS; Aghi MK; Muzikansky A; Shih HA; Barker FG; Curry WT
    J Clin Neurosci; 2014 Sep; 21(9):1490-6. PubMed ID: 24852903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brachyury Gly177Asp SNP is not associated with a risk of skull base chordoma in the Chinese population.
    Wu Z; Wang K; Wang L; Feng J; Hao S; Tian K; Zhang L; Jia G; Wan H; Zhang J
    Int J Mol Sci; 2013 Oct; 14(11):21258-65. PubMed ID: 24232574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descriptive epidemiology of chordomas in the United States.
    Das P; Soni P; Jones J; Habboub G; Barnholtz-Sloan JS; Recinos PF; Kshettry VR
    J Neurooncol; 2020 May; 148(1):173-178. PubMed ID: 32342333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and transcriptomic characterization of skull base chordoma.
    Sa JK; Lee IH; Hong SD; Kong DS; Nam DH
    Oncotarget; 2017 Jan; 8(1):1321-1328. PubMed ID: 27901492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
    Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
    Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T (brachyury) gene duplication confers major susceptibility to familial chordoma.
    Yang XR; Ng D; Alcorta DA; Liebsch NJ; Sheridan E; Li S; Goldstein AM; Parry DM; Kelley MJ
    Nat Genet; 2009 Nov; 41(11):1176-8. PubMed ID: 19801981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline findings in cancer predisposing genes from a small cohort of chordoma patients.
    Raygada M; John L; Liu A; Schultz J; Thomas BJ; Bernstein D; Miettinen M; Raffeld M; Xi L; Tyagi M; Aldape K; Glod J; Reilly KM; Widemann BC; Wedekind MF
    J Cancer Res Clin Oncol; 2024 May; 150(5):227. PubMed ID: 38700789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.
    Buccoliero AM; Caporalini C; Scagnet M; Baroni G; Moscardi S; Mussa F; Giordano F; Sardi I; Genitori L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):147-154. PubMed ID: 28777153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic targets in chordoma.
    Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
    Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
    Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
    Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
    Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
    J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.